Transgender or gender non-conforming cancer survivors had higher odds of most conditions compared to cisgender cancer survivors PHILADELPHIA –...
PHILADELPHIA – The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile...
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
Report features latest statistics and nine compelling patient stories PHILADELPHIA — The American Association for Cancer Research (AACR) today...
SAN DIEGO – A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
SAN DIEGO – Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated...
SAN DIEGO – AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recurrent...
SAN DIEGO – A blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the...
SAN DIEGO – TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease...
Patricia M. LoRusso, DO, PhD (hc), FAACR, begins term as AACR President SAN DIEGO – The members of the...